Clinical Trial Update: Anti PD-1 Antibody With Radiation Therapy in Patients With HER2-negative Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of an anti-PD-1 antibody with radiation therapy in HER2-negative metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anti-PD-1 antibody

Snippet

Sponsor: Kyoto Breast Cancer Research Network | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED